Which treatment is prescribed for oropharyngeal candidiasis?

Oropharyngeal candidiasis, also known as thrush, is a fungal infection caused by Candida species, most commonly Candida albicans. The treatment typically involves antifungal agents that are effective against these types of fungi.

Nystatin oral suspension is particularly effective for treating superficial candidal infections in the mouth. It works locally in the oropharyngeal mucosa, targeting the yeast organisms directly. This form of treatment is particularly beneficial because it has minimal systemic absorption, making it safe for use, even in patients with immune compromise or other contraindications for systemic antifungals.

Fluconazole, while effective for systemic or severe candidiasis, may not be the first choice for mild cases of oropharyngeal candidiasis due to its systemic nature. Clotrimazole tablets are also effective but are less commonly used in this specific context compared to nystatin. Acyclovir is an antiviral medication and is not effective against fungal infections, making it an inappropriate choice for this condition.

Thus, nystatin oral suspension is the preferred and correct treatment for managing oropharyngeal candidiasis due to its targeted action and safety profile.